TITLE

Advantages and Disadvantages of Beta- Adrenergic Blocking Drugs in Hypertension

AUTHOR(S)
O'Brien, Eoin T.
PUB. DATE
April 1978
SOURCE
Angiology;Apr1978, Vol. 29 Issue 4, p332
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This paper reviews the role of beta-adrenergic blocking drugs in the treatment of hypertension. A significant proportion of patients presenting with mild or moderate hypertension will respond to general measures and do not require specific drug therapy. Of the remaining patients, some will respond to treatment with a thiazide diuretic alone, and those with severe grades of hypertension will require the addition of a beta-adrenergic blocking drug, occasionally together with a vasodilator. The advantages of beta-adrenergic blocking drugs alone or in combination and the problems associated with therapy are discussed.
ACCESSION #
16388707

 

Related Articles

  • Treatment and prevention of hypertension: Where have we been and where are we going? Luft, Friedrich C. // Kidney International Supplement;Aug1995, Issue 50, pS-14 

    Explores the modality of treatment and prevention of hypertension. Identification of genes associated with blood pressure regulation and the development of hypertension; Application of diuretics and beta blockers; Influence of environmental factors on blood pressure.

  • CURRENT DRUG THERAPY IN HYPERTENSION. Brest, Albert N.; Moyer, John H. // Angiology;Feb1963, Vol. 14 Issue 2, p64 

    At present, diastolic hypertension can be controlled in the overwhelming majority of instances. However a double- or triple-drug regimen may be required in patients with moderate or severe diastolic blood pressure elevation.

  • Prostaglandins and Hypertension. Barger, A. Clifford // Angiology;Apr1978, Vol. 29 Issue 4, p320 

    Evidence is presented demonstrating the role of prostaglandins in salt metabolism and on peripheral vasodilation. A number of animal studies and observations in buman bypertensive subjects suggest that the prostaglandin system plays a role in the pathogenesis of hypertension. The most striking...

  • Refractory Hypertension in an Otherwise Healthy Adolescent. Davis, Charles A.; Kallen, Ronald J.; Goldberg, Alan D. // Clinical Pediatrics;Sep1981, Vol. 20 Issue 9, p587 

    Severe hypertension, for which no cause could be found, developed in an adolescent female. The patient's blood pressure was refractory to intensive pharmacologic intervention. After 1½ years of medical management, the patient's intra-arterial blood pressures were found to he in the...

  • Trends in hypertension management in Type I diabetes across Europe, 1989/1990 — 1997/1999 S.S. Soedamah-Muthu et al.: Hypertension management in Type I diabetes. Soedamah-Muthu, S.; Colhoun, H.; Abrahamian, H.; Chan, N.; Mangili, R.; Reboldi, G.; Fuller, J. // Diabetologia;Oct2001, Vol. 45 Issue 10, p1362 

    Aims/hypothesis. Our aim was to examine the change in the management of hypertension in patients with Type I (insulin-dependent) diabetes mellitus in Europe, between 1989–1990 and 1997–1999. Methods. Seven-year changes in hypertension treatment and control (defined as blood...

  • Efficacy of a Fixed-Dose Combination of Trandolapril-Verapamil in Patients with Stage 2 Hypertension Inadequately Controlled by Monotherapy. Alberto Francisco Rubio-Guerra; Arceo-Navarro, Adalberto; Lozano-Nuevo, José Juan; Vargas-Ayala, Germán; Rodríguez-López, Leticia; Ramos-Brizuela, Luz María // Clinical Drug Investigation;2005, Vol. 25 Issue 7, p445 

    Background and objective: About 70% of hypertensive patients need more than one drug to control their blood pressure (BP). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends a two-drug combination as initial...

  • Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study. de Simone, G.; Olsen, M. H.; Wachtell, K.; Hille, D. A.; Dahlöf, B.; Ibsen, H.; Kjeldsen, S. E.; Lyle, P. A.; Devereux, R. B. // Journal of Human Hypertension;Aug2007, Vol. 21 Issue 8, p625 

    The relation of metabolic syndrome (MetS) with cardiovascular outcome may be less evident when preclinical cardiovascular disease is present. We explored, in a post hoc analysis, whether MetS predicts cardiovascular events in hypertensive patients with electrocardiographic left ventricular...

  • GenSalt: rationale, design, methods and baseline characteristics of study participants.  // Journal of Human Hypertension;Aug2007, Vol. 21 Issue 8, p639 

    Hypertension is a complex disorder influenced by genetic and environmental determinants and their interactions. The objectives of the Genetic Epidemiology Network of Salt Sensitivity (GenSalt) are to localize and identify genes related to blood pressure (BP) responses to dietary sodium and...

  • Not enough heart going into severe hypertension management?  // PharmacoEconomics & Outcomes News;2/9/2008, Issue 546, p5 

    The article discusses research being done on the management of hypertension. It references a study conducted by researchers at the Duke University Medical Center. One of the researchers, Doctor Christopher Granger, states that despite an estimated 73 million people having high blood pressure in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics